Evidence map›Paper›PMID 29630398›Full record

ReviewThe British journal of radiology2018

Hossein Jadvar, Patrick M Colletti

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Comparison ofScientific reports · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hossein JadvarDivision of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA.ORCID http://orcid.org/0000-0002-9455-2484
Patrick M CollettiDivision of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA.
University of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Theranostics refers to companion agents with identical or similar structure targeted to a specific biological entity for imaging and treatment. Although the concept has a long history with radioiodine in thyroidology, but it has experienced remarkable recent renaissance in management of neuroendocrine tumors and prostate cancer. Bone scintigraphy based on osteoblastic reaction and targeted radionuclide therapy with the alpha-particle calcium-mimetic agent,

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsRadiumSodium FluorideHumansMaleNeoplasm MetastasisPositron Emission Tomography Computed TomographyProstatic NeoplasmsRadioactive TracersRadioisotopesTheranostic NanomedicineTreatment OutcomeFluorodeoxyglucose F18Radioactive TracersRadioisotopesRadiopharmaceuticalsRadiumradium Ra 223 dichlorideSodium Fluoride

Identifiers

PMID29630398
PMCPMC6475949
OpenAlexW2796757809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.